Treating chronic fascioliasis with oxfendazole or triclabendazole
Treatments studied
Part of Digestive system, Infections clinical trials.
This study compares two different medicines (oxfendazole and triclabendazole) to treat chronic fascioliasis, a parasitic liver infection. It aims to find the most effective and safe treatment option.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older.
- You have a confirmed fascioliasis infection from a stool test in the last 14 days.
- You have not been treated for fascioliasis before.
- You are not pregnant, planning to become pregnant, or nursing, and you agree to use birth control if needed.
- You do not have severe liver or kidney disease, or other conditions listed that could affect safety.
- You are not taking certain medications that may interfere with the study drugs.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial studies which dose of oxfendazole works best and is safest for treating a specific intestinal worm infection in adults. It compares different oxfendazole doses to one standard dose of albendazole, and uses stool and blood testing over about 4–6 weeks.
This study tests a medication called oxfendazole to see if it can get rid of whipworm infection in adults. Participants take the medication and provide stool samples over a few weeks to see if the worms are gone.
This study compares three medicines (albendazole, tribendimidine, and praziquantel) to see which works best for treating clonorchiasis (a liver fluke infection). If you have been diagnosed with this infection, this trial may help find the most effective treatment for you.
This study tests a medicine called oxfendazole (a type of anti-parasite drug, similar to albendazole) to treat a common form of brain infection caused by a pork tapeworm. If you have just one small lesion from this infection, this treatment may help reduce symptoms and prevent future seizures.
This trial tests whether giving treatment for schistosomiasis (a parasite infection) more often helps reduce liver scarring (fibrosis). It compares different schedules of medication to see which works best and may improve liver health.
This study tests if higher doses of arpraziquantel can safely treat children infected with the liver fluke Opisthorchis viverrini. It aims to find the best dose that clears the infection.
Hear when a new Fascioliasis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.